» Articles » PMID: 29843193

Large-scale Isolation, Expansion and Characterization of Human Amniotic Epithelial Cells

Overview
Date 2018 May 30
PMID 29843193
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The human Amniotic epithelial cells (AME) derived from amniotic membrane of placenta have been considered as the potential fetal stem cell source with minimal or no ethical concerns and are important therapeutic tool for anti-fibrotic and regenerative therapies.

Methods And Results: Here, we evaluated the isolation, media screening, scale-up and characterization of AME cells. The isolation, expansion of AMEs were performed by sequential passaging and growth kinetics studies. The AMEs were characterized using immunocytochemistry, immunophenotyping, differentiation, and anti-fibrotic assays. The growth kinetics study revealed that the AME cultured in Ultraculture (UC) and DMEM knockout (DMEM-KO) have prominently higher growth rate compared to others. Overall, the AMEs cultured from 5 different media retained basic morphological characteristics and the functional characteristics.

Conclusions: Our result suggests that the AMEs can be successfully cultured in UC based complete media without losing its epithelial cell characteristics even after passaging for passage 2 (P2). However, a careful and methodical pre-clinical and clinical translation studies need to be conducted to show its safety and efficacy.

Citing Articles

Human amniotic epithelial stem cells, a potential therapeutic approach for diabetes and its related complications.

Chen Z, Luo Y, Liu J Hum Cell. 2025; 38(2):39.

PMID: 39753919 DOI: 10.1007/s13577-024-01171-x.


Expansion of human amniotic epithelial cells using condition cell reprogramming technology.

Naeem A, Choudhry M, Kroemer A, Wahnschafft S, Cui W, Albanese C Hum Cell. 2022; 36(2):602-611.

PMID: 36586053 PMC: 9947022. DOI: 10.1007/s13577-022-00849-4.


Regulating Early Biological Events in Human Amniotic Epithelial Stem Cells Using Natural Bioactive Compounds: Extendable Multidirectional Research Avenues.

Ferdousi F, Isoda H Front Cell Dev Biol. 2022; 10:865810.

PMID: 35433672 PMC: 9011193. DOI: 10.3389/fcell.2022.865810.


A Survey and Critical Evaluation of Isolation, Culture, and Cryopreservation Methods of Human Amniotic Epithelial Cells.

Naeem A, Gupta N, Arzoo N, Naeem U, Khan M, Choudhry M Cell Cycle. 2022; 21(7):655-673.

PMID: 35289707 PMC: 8973348. DOI: 10.1080/15384101.2021.2020015.


Effects of Isorhamnetin on Diabetes and Its Associated Complications: A Review of In Vitro and In Vivo Studies and a Post Hoc Transcriptome Analysis of Involved Molecular Pathways.

Zar Kalai F, Boulaaba M, Ferdousi F, Isoda H Int J Mol Sci. 2022; 23(2).

PMID: 35054888 PMC: 8775402. DOI: 10.3390/ijms23020704.


References
1.
Miki T, Lehmann T, Cai H, Stolz D, Strom S . Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005; 23(10):1549-59. DOI: 10.1634/stemcells.2004-0357. View

2.
You H, Han S . Cell therapy for wound healing. J Korean Med Sci. 2014; 29(3):311-9. PMC: 3945123. DOI: 10.3346/jkms.2014.29.3.311. View

3.
Varkey M, Ding J, Tredget E . Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing. J Funct Biomater. 2015; 6(3):547-63. PMC: 4598670. DOI: 10.3390/jfb6030547. View

4.
Mason C, Brindley D, Culme-Seymour E, Davie N . Cell therapy industry: billion dollar global business with unlimited potential. Regen Med. 2011; 6(3):265-72. DOI: 10.2217/rme.11.28. View

5.
Miki T, Marongiu F, Dorko K, Ellis E, Strom S . Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol. 2010; Chapter 1:Unit 1E.3. DOI: 10.1002/9780470151808.sc01e03s12. View